The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 26, 2024

Filed:

Apr. 30, 2019
Applicant:

Sichuan Kelun-biotech Biopharmaceutical Co., Ltd., Sichuan, CN;

Inventors:

Hongmei Song, Sichuan, CN;

Xiaoxi Yuan, Sichuan, CN;

Jing Wang, Sichuan, CN;

Liang Xiao, Sichuan, CN;

Tongtong Xue, Sichuan, CN;

Ping Liu, Sichuan, CN;

Lichun Wang, Sichuan, CN;

Jingyi Wang, Sichuan, CN;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 47/68 (2017.01); A61K 9/00 (2006.01); A61K 31/337 (2006.01); A61K 31/555 (2006.01); A61P 35/00 (2006.01); C07K 16/32 (2006.01);
U.S. Cl.
CPC ...
A61K 31/555 (2013.01); A61K 9/0019 (2013.01); A61K 31/337 (2013.01); A61K 47/68031 (2023.08); A61K 47/6851 (2017.08); A61P 35/00 (2018.01); C07K 16/32 (2013.01);
Abstract

Disclosed in the present invention is the use of an anti-HER2 antibody-drug conjugate in cancer treatment. Further provided in the present invention is the use of a pharmaceutically acceptable salt, stereoisomer, or metabolite thereof, or a solvate of each of the foregoing in the manufacture of a medicament for the prophylaxis and/or treatment of a cancer insensitive or irresponsive to a treatment with a HER2-targeting agent.


Find Patent Forward Citations

Loading…